Host transcription profiles upon primary respiratory syncytial virus infection

Riny Janssen1, Jeroen Pennings, Hennie Hodemaekers

  • 1Laboratory for Toxicology, Pathology and Genetics, PB 12, National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands. riny.janssen@rivm.nl

Journal of Virology
|March 23, 2007
PubMed

Insights

Respiratory syncytial virus (RSV) infection triggers a rapid, early immune response in the lungs. This innate inflammation in the lungs dampens quickly, even before peak viral replication, offering insights into severe RSV disease.

Area of Science:

  • Immunology
  • Virology
  • Genetics

Background:

  • Respiratory syncytial virus (RSV) causes severe lower respiratory tract infections in children.
  • Severe RSV disease is linked to an aberrant immune response and host genetic factors influencing lung pathology.

Purpose of the Study:

  • To investigate early pathogenic pathways and immune responses to RSV infection.
  • To identify candidate genes for genetic studies in children with severe RSV.

Main Methods:

  • Transcriptional profiling of mouse lungs and lymph nodes at 1 and 3 days post-RSV infection.
  • Analysis of gene expression patterns related to innate immunity, inflammation, and antigen processing.

Main Results:

  • RSV infection induced a rapid, transient pro-inflammatory response in the lungs, characterized by upregulated interferon- and chemokine-related genes.
  • The strong transcriptional response in the lung occurred before peak viral replication and dampened by day 3.
  • Lung-draining lymph node responses were less pronounced, suggesting NK cell activation.

Conclusions:

  • The early, localized lung transcriptional response to RSV infection diminishes before significant viral load and inflammatory cell infiltration.
  • These findings provide a basis for selecting candidate genes in human genetic studies of severe RSV infection.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: